Eczema care solution

Abstract

The invention discloses an eczema care solution which is applied to the treatment of eczema. The eczema care solution is characterized by being prepared from a plurality of traditional Chinese medicines, and contains the following raw pharmaceutical materials in parts by weight: 10-20 parts of honeysuckle stem, 10-20 parts of dahurian angelica root, 15-20 parts of cortex dictamni, 10-15 parts of cocklebur fruit, 1-3 parts of chaulmoogra, 10-15 parts of five-leaf akebia fruit, 10-20 parts of red peony root, 6-12 parts of codonopsis lanceolata, 6-12 parts of polygonum orientale fruit, 6-12 parts of chinaroot greenbrier, 10-15 parts of buchnera cruciata and 6-12 parts of verbena. Proved by clinical trials, the eczema care solution has the characteristics of good treatment effect and relatively high safety in the treatment of eczema, so that the eczema care solution is worthy of clinical application and popularization.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to an eczema care solution. Background technique [0002] Eczema is a common chronic, relapsing, and inflammatory skin disease, which is caused by a variety of internal and external factors, and is related to skin barrier dysfunction, atopic constitution of patients, and allergic reactions mediated by food and environmental allergens. The disease has obvious itching and repeated illnesses, which seriously affects the quality of life of patients, especially the quality of sleep. The usual Western medicine treatment is antihistamines and glucocorticoids, but if the patient needs long-term treatment or the treated lesions are too large, the systemic absorption of topical glucocorticoids may trigger the hypothalamus-pituitary-adrenal axis ( HPA) axis inhibition and other adverse reactions. Studies in recent years have also shown that the colonization rate of Staphylococcus ...

AI Technical Summary

Problems solved by technology

The usual Western medicine treatment is antihistamines and glucocorticoids, but if the patient needs long-term treatment or the treated lesions are too large, the systemic absorption of topical glucocorticoids may trigger the hypothalamus-pituitary-adrenal axis ( HPA) axis inhibition and other adverse reactions

Studies in recent years have also shown that the colonization rate of Staphylococcus aureus on the skin of patients with eczema is significantly higher than that of normal people, and the severity of skin lesions is positively correlated with the number of bacterial colonization. The exotoxin released by Staphylococcus aureus can induce and aggravate Eczema, and induce the expression of glucocorticoid β receptors, thereby inhibiting glucocorticoid α receptors, making T cells insensitive to glucocorticoids and affecting the curative effect, thus reducing the effectiveness of traditional treatment options

In addition, hormones or ointments can be used for small areas of eczema, but if used for large areas of eczema, it is inconvenient to use and has many side effects

The curative effect of traditional Chinese medicine in treating eczema is remarkable, and the treatment is often based on expelling wind and dampness, and clearing away heat. However, this treatment plan is not effective for intractable eczema. Blood stasis, heat, dampness, and blood fight together to cause the disease, and there is still a lack of clinical medicine or nursing products based on blood points